PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer

PURPOSE: In this study we addressed the underlying mechanisms for the association between enzalutamide treatment and NEPC, and the critical involvement of MYCN, and loss of RB1 function in NED of prostatic epithelial cells, and the development of NEPC. We further sought to determine whether PARP inh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: Liu, Bo, Li, Likun, Yang, Guang, Geng, Chuandong, Luo, Yong, Wu, Wenhui, Manyam, Ganiraju C., Korentzelos, Dimitrios, Park, Sanghee, Tang, Zhe, Wu, Cheng, Dong, Zhenyang, Sigouros, Michael, Sboner, Andrea, Beltran, Himisha, Chen, Yu, Corn, Paul G., Tetzlaff, Michael T., Troncoso, Patricia, Broom, Bradley, Thompson, Timothy C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858969/
https://ncbi.nlm.nih.gov/pubmed/31439587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0317
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares